REG - Natwest Markets PLC - NatWest Markets Plc Pricing Supplement

NatwestAnnouncement

01/04/2022 18:15

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20220401:nRSA0390Ha&default-theme=true

RNS Number : 0390H  Natwest Markets PLC  01 April 2022

NatWest Markets Plc Pricing Supplement

The following Pricing Supplement is available for viewing:

Pricing Supplement dated 31 March 2022 (the "Pricing Supplement") for NatWest
Markets Plc ("NatWest Markets") for the CHF 300,000,000 0.8975 per cent. Notes
due 4 April 2025 (ISIN: CH1167887277) (the "Notes") issued under the
£15,000,000,000 Euro Medium Term Note Programme of NatWest Markets (the
"Programme").

The Pricing Supplement contains the final terms of the Notes and must be read
in conjunction with the prospectus dated 7 December 2021 and the supplemental
prospectus dated 18 February 2022 and the supplemental prospectus dated 17
March 2022 relating to the Programme (together, the "Prospectus"), which
constitute a base prospectus for the purposes of the Prospectus Regulation
(EU) 2017/1129 as it forms part of domestic law in the UK by virtue of the
European Union (Withdrawal) Act 2018.

To view the Pricing Supplement, please paste the following URL into the
address bar of your browser:

http://www.rns-pdf.londonstockexchange.com/rns/0390H_1-2022-4-1.pdf
(http://www.rns-pdf.londonstockexchange.com/rns/0390H_1-2022-4-1.pdf)

A copy of the above Pricing Supplement has been submitted to the National
Storage Mechanism and will shortly be available for inspection at:

https://data.fca.org.uk/#/nsm/nationalstoragemechanism
(https://data.fca.org.uk/#/nsm/nationalstoragemechanism)

For further information, please contact:

Mark Anwender

Head of Documentation and Funding

NatWest Treasury Markets

Tel: +44 7385 366760

 

DISCLAIMER - INTENDED ADDRESSEES

Please note that the information contained in the Pricing Supplement (when
read together with the information in the Prospectus) may be addressed to
and/or targeted at persons who are residents of particular countries
(specified in the Prospectus) only and is not intended for use and should not
be relied upon by any person outside these countries and/or to whom the offer
contained in the Pricing Supplement and the Prospectus is not addressed. Prior
to relying on the information contained in the Pricing Supplement and the
Prospectus, you must ascertain from the Prospectus whether or not you are part
of the intended addressees of the information contained therein.

Your right to access this service is conditional upon complying with the above
requirement.

NatWest Markets Plc -  RR3QWICWWIPCS8A4S074

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  PSPUPURACUPPGAG